Marcelino Bermudez Lopez
Grau: Doctor/a
973702482
mbermudez(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/C-3787-2011
Publicacions
-
Palanca, A; Castelblanco, E; Betriu À; Perpiñán H; Soldevila, B; Valdivielso, JM; Bermudez-Lopez, M; Puig-Jove, C; Puig-Domingo, M; Groop, PH; Fernandez, E; Alonso, N; Mauricio, D
Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
Cardiovascular Diabetology 18 93-93. .
-
Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM
An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
Expert Opinion On Therapeutic Targets 23 619-630. .
-
Sánchez M; Sánchez E; Hernández M; González J; Purroy F; Rius F; Pamplona R; Farràs-Sallés C; Gutiérrez-Carrasquilla L; Fernández E; Bermúdez-López M; Salvador J; Salas-Salvadó J; Lecube A
Dissimilar Impact of a Mediterranean Diet and Physical Activity on Anthropometric Indices: A Cross-Sectional Study from the ILERVAS Project
Nutrients 11 -. .
-
Cambray, S; Galimudi, RK; Bozic, M; Bermudez-Lopez, M; Rodriguez, I; Valdivielso, JM
A The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort
Journal of Clinical Medicine 8 -. .
-
Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project
Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project
Journal of Atherosclerosis and Thrombosis 26 879-889. .
-
Valls J; Cambray S; Pérez-Guallar C; Bozic M; Bermúdez-López M; Fernández E; Betriu À; Rodríguez I; Valdivielso JM
Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort
Frontiers in Genetics 10 118-118. .
-
Borràs, Mercè; Cambray, Serafí; Crespo-Masip, Maria; Pérez-Fontán, Miguel; Bozic, Milica; Bermudez-López, Marcelino; Fernández, Elvira; Betriu, Àngels; Valdivielso, José M.
Peritoneal Dialysis Is an Independent Factor Associated to Lower lntima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease
Frontiers in physiology 9 1743-1743. .
-
Palanca, A; Castelblanco, E; Perpinan, H; Betriu, A; Soldevila, B; Valdivielso, JM; Bermudez, M; Duran, X; Fernandez, E; Puig-Domingo, M; Groop, PH; Alonso, N; Mauricio, D
Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes
Atherosclerosis 276 50-57. .
-
Bozic M; Betriu A; Bermudez-Lopez M; Ortiz A; Fernandez E; Valdivielso JM
Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients
Clinical Journal Of The American Society Of Nephrology 13 577-584. .
-
Bermudez-Lopez, M; Betriu À; Valdivielso, JM; Bretones Del Pino T; Arroyo, D; Fernandez, E
Beyond the traditional lipid parameters in chronic kidney disease
Nefrologia 38 109-113. .
-
Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E
Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound
PLOS ONE 12 -. .
-
Bermudez-Lopez, M; Arroyo, D; Betriu À; Masana, L; Fernandez, E; Valdivielso, JM
New perspectives on CKD-induced dyslipidemia
Expert Opinion On Therapeutic Targets 21 967-976. .
Projectes
- ANGEL: A machine learning algorithm to predict atherosclerotic cardiovascular disease.
- Impacto del Manejo de los Trastornos Respiratorios Durante el Sueño en el control de la hipertensión sistémica: Proyecto METASLEEP
- Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
- Projecte d'Investigació ILERVAS - 2022
- Ayudas Juan de la Cierva - Incorporación 2018
- Projecte d'investigació ILERVAS -2020 Diputació
- Caracterización de un perfil lipidomico y lipídico de riesgo aterogénico y de morbimortalidad cardiovascular en la enfermedad renal crónica (estadios 3 a 5) (estudio prospectivo NEFRONA)
- AJUT PER A LA CONTRACTACIÓ D'UN NOU INVESTIGADOR
